Acute Tumor Lysis Syndrome with Choriocarcinoma

Southern Medical Journal

Volumn 93, Issue 9, 2000, Pages 916-919

  Blanke, Charles D ^a,b   Hemmer, Maj Paul A ^a   Witte, Robert S ^a  

^a LaCrosse Lutheran Hospital   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; CISPLATIN; ETOPOSIDE; PHOSPHATE; URIC ACID;

ACIDOSIS; ACUTE DISEASE; ARTICLE; BLOOD; CASE REPORT; CHORIOCARCINOMA; FATALITY; HEART ARREST; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; RESPIRATORY FAILURE; TESTIS TUMOR; TUMOR LYSIS SYNDROME;

ACIDOSIS; ACUTE DISEASE; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHORIOCARCINOMA; CISPLATIN; ETOPOSIDE; FATAL OUTCOME; HEART ARREST; HUMANS; HYPERKALEMIA; HYPOCALCEMIA; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHOSPHATES; RESPIRATORY INSUFFICIENCY; TESTICULAR NEOPLASMS; TUMOR LYSIS SYNDROME; URIC ACID;

EID: 0034267647     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200093090-00017     Document Type: Article

References (32)

1. Cohen LF, Balow JE, Magrath I, et al: Acute tumor lysis syndrome: a review of 37 patients with Burkitt's lymphoma. Am J Med 1980; 68:486-491
2. Tsokos GC, Balow JE, Speigel RJ, et al: Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine 1971; 60:218-229
3. Zusman J, Brown DM, Nesbit ME: Hyperphosphatemia, hypophosphaturia and hypocalcemia in acute lymphoblastic leukemia. N Engl J Med 1973; 289:1335-1340
4. Stark ME, Dyer CD, Coonley CJ: Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer 1987; 60:762-764
5. Barton JC: Tumor lysis syndrome in nonhematopoietic neoplasms. Cancer 1989; 64:739-740
6. Vogelzang NJ, Nelimark RA, Nath KA: Tumor lysis syndrome after induction chemotherapy of small cell bronchogenic carcinoma. JAMA 1983; 249:513-514
7. Hussein AM, Fuen LG: Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma. Am J Clin Oncol 1990; 13:10-13
8. Dirix LY, Prove A, Becquart D, et al: Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 1991; 67:2207-2210
9. Tomlinson GC, Solberg LA Jr: Acute tumor lysis syndrome with metastatic medulloblastoma. Cancer 1984; 53:1783-1785
10. Parsons DA, Garst J, Vollmer R, et al: Tumor lysis syndrome and acute renal failure after treatment of non-small cell lung carcinoma with combination irinotecan and cisplatin. Am J Clin Oncol 1998; 21:426-429
11. Bilgrami SF, Fallon BG: Tumor lysis syndrome after combination chemotherapy for ovarian cancer. Med Pediatr Oncol 1993; 21:521-524
12. Yokoi K, Miyazawa N, Kano Y, et al: Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis. Am J Clin Oncol 1997; 20:86-89
13. Khalil A, Chammas M, Shamseddine A, et al: Fatal acute tumor lysis syndrome following treatment of vulvar carcinoma: case report. Eur J Gynaecol Oncol 1998; 19:415-416
14. Shamseddine AI, Khalil AM, Wehbeh MH: Acute tumor lysis syndrome with squamous cell carcinoma of the vulva. Gynecol Oncol 1993; 51:258-260
15. Khan J, Broadbent VA: Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 1993; 10:151-155
16. Boisseau M, Bugat R, Mahjoubi M: Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment with irinotecan (CPT-11). Eur J Cancer 1996; 32A:737-738
17. Crittenden DR, Ackerman GL: Hyperuricemic acute renal failure in disseminated carcinoma. Arch Intern Med 1977; 137:97-99
18. Stewart DJ, Dulberg CS, Mikhael NZ: Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods. Cancer Chemother Pharmacol 1997; 40:293-308
19. Lagrange JL, Medecin B, Etienne MC, et al: Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors. Pharmacotherapy 1997; 17:1246-1253
20. Jacobs C, Bertino JR, Goffinet DR, et al: 24-hour infusion of cisplatin in head and neck cancers. Cancer 1978; 42:2135-2140
21. Salem P, Khalyl M, Jabboury K, et al: Cisdiammine-dichloroplatinum (II) by 5-day continuous infusion. Cancer 1984; 53:837-840
22. Izumi T: Experimental studies on the nephrotoxicity of cisplatin. amelioration of nephrotoxicity by continuous infusion. Hinyokika Kiyo 1988; 34:37-45
23. Erlichman C, Soldin SJ, Thiessen JJ, et al: Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer. Cancer 1987; 19:75-79
24. Reece PA, Staffor I, Russel J, et al: Reduced ability to clear ultrafiltrable platinum with repeated courses of cisplatin. J Clin Oncol 1986; 4:1392-1398
25. Benditt JO, Farber HW, Wright J, et al: Pulmonary hemorrhage with diffuse alveolar infiltrates in men with high volume choriocarcinoma. Ann Intern Med 1988; 109:674-675
26. Logothetis CJ: Choriocarcinoma syndrome. Cancer Bull 1984; 36:118-120
27. Bower M, Newlands ES, Holden L, et al: EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997; 15:2636-2643
28. Newlands ES, Bagshawe KD, Begent RHJ, et al: Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol 1986; 58:307-314
29. Charbit A, Malaise EP, Tubiana M: Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer 1971; 7:307-315
30. Nichols CR: Testicular cancer. Current Probl Cancer 1998; 22:187-274
31. Kattan J, Culine S, Tavakoli-Razavi T, et al: Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist? Support Care Cancer 1994; 2:128-131
32. Kalemkerian GP, Darwish B, Varterasian ML: Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med 1997; 103:363-367